Summary
Serum specimens from 152 Sicilian multitransfused thalassemic subjects were tested for antibodies to hepatitis C virus (anti- HCV) and for HBV markers by enzyme linked immunoassay and with reference to anti-HCV, confirmed by recombinant immunoblot assay. A high rate (47%) of subjects was anti-HCV positive. HBsAg was found in 8% of patients and 55% had anti-HBs or anti-HBc antibodies or both. Contrary to HBV infection, anti-HCV seropositivity was related to the number of transfused units. The highest anti-HCV prevalence was observed between 16 and 20 years; 100% of persons older than 50 years had at least one marker of HBV infection. In conclusion, HCV and HBV are widespread among multitransfused thalassemics. Probably in our area, particularly during the pre-HBsAg screening era, several multitransfused patients were infected by HBV more readily than by HCV.
Zusammenfassung
Die Seren von 152 Thalassämie-Patienten, die häufig Bluttransfusionen erhalten hatten, wurden auf Antikörper gegen Hepatitis-C-Virus und HBV-Marker getestet. Ein hoher Prozentsatz (47%) erwies sich als anti-HCV positiv, was mit RIBA bestätigt wurde. HBsAg wurde bei 8% der Patienten gefunden und 55% hatten anti-HBc-oder Anti-HBs-Antikörper. Die dominierende anti-HCV-Prävalenz stand in Beziehung zur Transfusionshäufigkeit und war zwischen dem 16. und 20. Lebensjahr am höchsten. Im Gegensatz dazu stand die HBV-Infektion nicht im Verhältnis zu der Anzahl der Bluttransfusionen; bei 100% der Patienten über 50 Jahre wurde mindestens ein HBV-Infektionsmarker beobachtet. Bei Thalassämie-Patienten sind HCV- und HBV-Infektionen verbreitet. Wahrscheinlich haben sich vor dem Beginn des HBsAg-Screening in den Blutbanken viele Patienten mit dem HB-Virus infiziert.
Similar content being viewed by others
References
Tremolada, F., Chiappetta, F., Noventa, F., Valfrè, C., Ongaro, G., Realdi, G. Prospective study of post-transfusion hepatitis in cardiac surgery patients receiving only blood or also blood products. Vox Sang. 44 (1983) 25–30.
Colombo, M., Oldani, S., Donato, M. F., Borzio, M., Santese, R., Roffi, L., Vigano, P., Cargnel, A. A multicenter prospective study of posttransfusion hepatitis in Milan. Hepatology 7 (1987) 709–712.
Hernandez, J. M., Piqueras, J., Carrera, A., Triginer, J. Posttransfusion hepatitis in Spain. A prospective study. Vox. Sang. 44 (1983) 231–237.
Gaeta, G. B., Giusti, G. Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends. Infection 18 (1990) 21–25.
Feinstone, S. M., Kapikian, A. Z., Purcell, R. H., Alter, H. J., Holland, P. V. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N. Engl. J. Med. 292 (1975) 767–770.
Esteban, J. I., Gonzales, A., Hernandez, J. M., Viladamiou, L., Sanchez, C., Lopez-Talavera, J. G., Lucea, D., Martin-Vega, C., Vidal, X., Esteban, R., Guardia, J. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N. Engl. J. Med. 323 (1990) 1107–1112.
Mele, A., Stazi, M. A., Corona, R., Ferrigno, L., Sagliocca, L., Palumbo, F., Falasca, P., Galanti, C., Moiraghi, A., Rosmini, F., Gill, O. N., Pasquini, P. andSeieva collaborating group Decline of incidence of A, B and non-A non-B hepatitis in Italy. Results of four year surveillance (1985–88). Ital. J. Gastroent. 22 (1990) 274–280.
Dienstag, J. L., Alter, H. J. Non A Non B hepatitis: evolving epidemiologic and clinical perspective. Semin. Liver Dis. 6 (1986) 67–81.
Rakela, J., Redeker, A. G. Chronic liver disease after acute non A non B viral hepatitis. Gastroenterology 77 (1979) 1200–1202.
Realdi, G., Alberti, A., Rugge, M., Rigoli, A. M., Tremolada, F., Schivazappa, L., Ruol, A. Long term follow-up of acute and chronic non A non B post-transfusion hepatitis evidence of progression to liver cirrhosis. Gut 23 (1982) 270–275.
Alter, H. J., Prince, A. M. Transfusion associated non A non B hepatitis: an assessment of the causative agent and its clinical impact. Transf. Med. Rev. 2 (1988) 288–293.
Polesky, H. F., Hanson, M. R. Transfusion associated hepatitis C virus (non A non B) infection. Arch. Pathol. Lab. Med. 113 (1989) 232–235.
Alter, H. J. Transfusion associated non A non B hepatitis. In:Zuckerman, A. J. (ed.): The first decade in viral hepatitis and liver disease. Liss, New York 1988, pp. 537–542.
Van der Poel, C. L., Reesink, H. W., Cuypers, H. Th., Lelie, P. N., Schaasberg, W. Is anti HCV blood donor screening useful? Lancet ii (1990) 1193.
Sirchia, F., Bellobuono, A., Giovanetti, A., Marconi, A. Antibodies to hepatitis C virus in Italian blood donors. Lancet i (1989) 797.
Di Giorgio, G., Martini, E., Centra, M., Di Mauro, L., Colella, F., Bisogno, R., Ciavarella, G.: Hepatitis C virus antibodies and HBV markers among multitransfused thalassemics. Presented at the International Symposium on Progress and Prospects in Viral Hepatitis, Bari, Feb. 15–17, 1990.
Taliani, G., Vanie, A., Aliquo, M. C., Maiozzi, S., Di Gilio, G., Bianco, I., Monti, S., De Bac, C., Nigro, G.: Antibodies to hepatitis C virus in thalassemic patients. Presented at the Second International Conference, “Current trends in chronically evolving viral hepatitis,” Siena, Oct. 24–27, 1990.
Maggio, A., Magrin, S., Renda, D., Capra, M., Diprima, S., Lojacono, F., Pitrolo, L., Scarfia, M. F., Rizzo, M., Di Marco, V., Craxi, A., Marino, L., Fiorentino, G.: HCV infection in polytransfused Italian subjects with β-thalassemia. Presented at the International Symposium on Progress and Prospect in Viral Hepatitis, Bari, Feb. 15–17, 1990.
Sofroniadou, K., Kokkini, G., Drosou, M., Tselikis, B., Papanostesopoulos, B., Andrioopoulou, E.: Hepatitis C virus antibody prevalence in multitransfused Greek patients. Presented at the International Society of Blood Transfusion/American Association of Blood Banks Joint Congress, Los Angeles, Nov. 10–15, 1990.
de Montalembert, M., Lefrere, J. J., Michel, G., Perrimond, H., Girot, R.: Prévalence des infections virales transfusionnelles chez les patients thalassémiques transfusés en concentrés erythrocitaires. Presented at the 4èmes Journées Méditerrannéennes de Transfusion sanguine, Nice, Oct. 11–12, 1990.
Greco, G., Vella, F., Modugno, A., Fiore, G., Giannelli, G., Volpe, A., Zavoianni, A., Dentico, P., De Rinaldis, P., Schiraldi, O.: HCV antibody and liver damage in a cohort of thalassemics from Salento. Presented at the Second International Conference, “Current trends in chronically evolving viral hepatitis,” Siena, Oct. 24–27, 1990.
Rumi, M. G., Colombo, M., Gringeri, A., Mannucci, P. M. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. Ann. Intern. Med. 112 (1990) 379–380.
Alter, H. J., Purcell, R. H., Shih, J. W. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non A non B hepatitis. N. Engl. J. Med. 321 (1989) 1494–1500.
Stroffolini, T., Craxi, A., Giammanco, A., De Crescenzo, L., Intanazzo, V., La Rosa, G., Cascio, A., Taormina, S., Chiarini, A., Dardanoni, L. Hepatitis B virus infection in children in Palermo. Ital. J. Gastroenterol. 21 (1989) 276–278.
Pasquini, P., Kahn, H. A., Pileggi, D., Panà, A., Terzi, I., Guzzanti, F. Prevalence of hepatitis B markers in Italy. Am. J. Epidemiol. 118 (1983) 699–709.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cacopardo, B., Russo, R., Fatuzzo, F. et al. HCV and HBV infection among multitransfused thalassemics from Eastern Sicily. Infection 20, 83–85 (1992). https://doi.org/10.1007/BF01711069
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01711069